IL150525A0 - 2-carboxamide-benzimidazoles useful in the treatment and prevention of isochemic reperfusion injury - Google Patents
2-carboxamide-benzimidazoles useful in the treatment and prevention of isochemic reperfusion injuryInfo
- Publication number
- IL150525A0 IL150525A0 IL15052501A IL15052501A IL150525A0 IL 150525 A0 IL150525 A0 IL 150525A0 IL 15052501 A IL15052501 A IL 15052501A IL 15052501 A IL15052501 A IL 15052501A IL 150525 A0 IL150525 A0 IL 150525A0
- Authority
- IL
- Israel
- Prior art keywords
- isochemic
- carboxamide
- prevention
- treatment
- reperfusion injury
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Gastroenterology & Hepatology (AREA)
- Vascular Medicine (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18123400P | 2000-02-09 | 2000-02-09 | |
PCT/US2001/004211 WO2001058878A1 (en) | 2000-02-09 | 2001-02-08 | 2-carboxamide-benzimidazoles useful in the treatment and prevention of ischemic reperfusion injury |
Publications (1)
Publication Number | Publication Date |
---|---|
IL150525A0 true IL150525A0 (en) | 2003-02-12 |
Family
ID=22663432
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL15052501A IL150525A0 (en) | 2000-02-09 | 2001-02-08 | 2-carboxamide-benzimidazoles useful in the treatment and prevention of isochemic reperfusion injury |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1263736A1 (en) |
JP (1) | JP2003522759A (en) |
AU (1) | AU2001236821A1 (en) |
CA (1) | CA2399795A1 (en) |
IL (1) | IL150525A0 (en) |
NO (1) | NO20023752L (en) |
WO (1) | WO2001058878A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6872827B2 (en) | 2002-04-26 | 2005-03-29 | Chembridge Research Laboratories, Inc. | Somatostatin analogue compounds |
CN108456171B (en) * | 2018-03-16 | 2021-07-27 | 中山大学肿瘤防治中心(中山大学附属肿瘤医院、中山大学肿瘤研究所) | FLT3/ITD mutant inhibitor and application thereof in tumor prevention and treatment medicines |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SK18542000A3 (en) * | 1998-06-04 | 2001-12-03 | Abbott Laboratories | Cell adhesion-inhibiting anti-inflammatory compounds |
-
2001
- 2001-02-08 JP JP2001558429A patent/JP2003522759A/en not_active Withdrawn
- 2001-02-08 EP EP01909025A patent/EP1263736A1/en not_active Withdrawn
- 2001-02-08 AU AU2001236821A patent/AU2001236821A1/en not_active Abandoned
- 2001-02-08 CA CA002399795A patent/CA2399795A1/en not_active Abandoned
- 2001-02-08 WO PCT/US2001/004211 patent/WO2001058878A1/en not_active Application Discontinuation
- 2001-02-08 IL IL15052501A patent/IL150525A0/en unknown
-
2002
- 2002-08-08 NO NO20023752A patent/NO20023752L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO20023752L (en) | 2002-10-09 |
JP2003522759A (en) | 2003-07-29 |
WO2001058878A1 (en) | 2001-08-16 |
EP1263736A1 (en) | 2002-12-11 |
CA2399795A1 (en) | 2001-08-16 |
NO20023752D0 (en) | 2002-08-08 |
AU2001236821A1 (en) | 2001-08-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001293553A1 (en) | Phosphatidylserine-carrying apoptosis-mimicking bodies and the use thereof in medical treatment | |
AU8870701A (en) | Materials and methods for the treatment or prevention of obesity | |
HK1054225A1 (en) | Mch antagonists and their use in the treatment of obesity | |
EP1343726A4 (en) | Processes and compositions for water treatment | |
ZA200300788B (en) | Improvements in and relating to the use of honey in dressings. | |
IL156340A0 (en) | 3-indoline derivatives useful in the treatment of psychiatric and neurologic disorders | |
HUP0400069A3 (en) | Pharmaceutical combinations and their use in preventing and treating the thrombosis | |
AU7790401A (en) | Compositions and methods of preventing or reducing the risk or incidence of skeletal injuries in horses | |
GB2314273B (en) | The use of TCET in the prophylaxis and treatment of allergies | |
PL352333A1 (en) | Dihydrobenzodiazepines and use of same in treatment of dislipidemia | |
AU2002243363A8 (en) | Use of aziridino-compounds in the treatment of immune dysfunctions | |
AU6814601A (en) | Use of mutant herpes viruses and anticancer agents in the treatment of cancer | |
AU9279601A (en) | Compounds and methods for use thereof in the treatment of cancer or viral infections | |
HUP0302738A3 (en) | Use of sarp-1 for the treatment and/or prevention of scleroderma | |
IL150525A0 (en) | 2-carboxamide-benzimidazoles useful in the treatment and prevention of isochemic reperfusion injury | |
AU7570201A (en) | Phenylethylamine derivatives and their use in the treatment of melanoma | |
GB0004534D0 (en) | Hair treatment compositions and their use | |
GB0007217D0 (en) | Materials and methods relating to the treatment of leukaemias | |
GB0004535D0 (en) | Hair treatment compositions and their use | |
ZA200103250B (en) | The treatment of immunomodulatory related and other diseases or conditions. | |
GB0112905D0 (en) | Biological materials and methods for use in the prevention or treatment of infections | |
GB0004648D0 (en) | Compositions and mixtures for the treatment of skin | |
GB0020170D0 (en) | Sedative materials and treatment | |
GB0018376D0 (en) | Phenylethylamine derivatives and their use in the treatment of melanoma | |
GB0027574D0 (en) | Phenylethylamine derivatives and their use in the treatment of melanoma |